NovaBridge Biosciences (NBP)

↓ Download CSV

CIK 0001778016 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated E9
  • Fiscal year ends Dec 31
Metric (FY)2025202420232022202120202019201820172016
Revenue27.64M CNY-221.56M CNY88.03M CNY1.54B CNY
Cost of Revenue27.24M CNY46.43M CNY0 CNY0 CNY
Net Income-1.47B CNY-2.51B CNY-2.33B CNY470.92M CNY-1.45B CNY-402.83M CNY-298.24M CNY
EPS (Diluted)-7.66 CNY-13.21 CNY-13.35 CNY3.00 CNY-201.19 CNY-61.70 CNY-51.93 CNY
Total Assets2.61B CNY4.07B CNY5.60B CNY6.33B CNY1.74B CNY2.38B CNY
Total Liabilities894.81M CNY1.16B CNY1.04B CNY706.65M CNY668.09M CNY415.68M CNY
Shareholders' Equity1.72B CNY2.91B CNY4.56B CNY5.63B CNY-2.03B CNY-955.10M CNY-299.80M CNY-14.51M CNY
Cash & Equivalents2.14B CNY3.21B CNY3.52B CNY4.76B CNY1.14B CNY1.59B CNY
Capital Expenditures11.35M CNY45.83M CNY29.93M CNY8.01M CNY12.24M CNY14.41M CNY20.33M CNY
Shares Outstanding220.26M186.73M191.42M189.79M174.71M157.23M7.38M6.53M5.74M